VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,428,000 | +543.2% | 8,000 | +700.0% | 0.09% | +760.0% |
| Q2 2015 | $222,000 | -95.8% | 1,000 | -97.3% | 0.01% | -96.5% |
| Q4 2014 | $5,329,000 | -36.5% | 37,240 | -41.8% | 0.28% | -34.5% |
| Q3 2014 | $8,397,000 | +56.7% | 64,000 | +50.6% | 0.43% | +51.6% |
| Q2 2014 | $5,360,000 | -25.0% | 42,500 | -21.6% | 0.28% | -9.5% |
| Q1 2014 | $7,148,000 | -78.6% | 54,223 | -80.9% | 0.32% | -77.7% |
| Q4 2013 | $33,383,000 | -2.9% | 284,352 | -13.7% | 1.41% | -3.2% |
| Q3 2013 | $34,377,000 | -21.7% | 329,498 | -35.4% | 1.46% | -37.5% |
| Q2 2013 | $43,918,000 | – | 510,203 | – | 2.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
| FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
| LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
| Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
| ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
| White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
| Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
| Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
| Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
| Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |